Skip to main content
Log in

Parkinsonism and inborn errors of metabolism

  • ICIEM Symposium 2013
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Parkinsonism is a frequent neurological syndrome in adulthood but is very rare in childhood. Early forms of Parkinsonism have many distinctive features as compared to Parkinsonism in adults. In fact, rather than Parkinsonism, the general concept “hypokinetic-rigid syndrome” (HRS) is more accurate in children. In general, the terms “dystonia-parkinsonism”, “parkinsonism-plus”, or “parkinsonism-like” are preferred to designate these forms of paediatric HRS. Inborn errors of metabolism (IEM) constitute an important group amongst the genetic causes of Parkinsonism at any age. The main IEM causing Parkinsonism are metal-storage diseases, neurotransmitter defects, lysosomal storage disorders and energy metabolism defects. IEM should not be neglected as many of them represent treatable causes of Parkinsonism. Here we review IEMs causing this neurological syndrome and propose diagnostic approaches depending on the age of onset and the associated clinical and neuroimaging features.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AADC:

Aromatic L-amino acid decarboxylase

AD:

Autosomal dominant

AR:

Autosomal recessive

BH4:

Tetrahydrobiopterin

BP:

Biopterin

CNL:

Ceroid lipofuscinosis

CSF:

Cerebrospinal fluid

CTX:

Cerebrotendinous xanthomatosis

GABA:

Gamma-aminobutyric acid

GM1:

GM1 gangliosidosis

GPe:

globus pallidus (pars externa)

GPi:

The globus pallidus (pars interna)

GTPCH:

Guanosine triphosphate cyclohydrolase-I

5-HIAA:

5-hydroxyindolacetic acid

HRS:

Hypokinetic rigid syndrome

HVA:

Homovanillic acid

IBZM:

Iodobenzamide

IEM:

Inborn errors of metabolism

MAO:

Monoamine oxidase

MRI:

Magnetic resonance imaging

NMDAR:

N-methyl-D-aspartate receptor

NBIA:

Neurodegeneration with brain iron accumulation

NP:

Neopterin

NT:

Neurotransmitter

PC:

Pyruvate carboxylase

PD:

Parkinson's disease

PET:

Positron emission tomography

PKAN:

Pantothenate kinase- associated neurodegeneration

PTPS:

6-pyruvoyl-tetrahydropoterin synthase

SPN:

Spiny projection neurons

SN:

Substantia nigra

SNc:

Substantia nigra compacta

SNr:

Substantia nigra reticulata

SPECT:

Single-photon emission computed tomography

STN:

Subthalamic nucleus

TH:

Tyrosine hydroxylase

VLA:

Vanillactic acid

YOPD:

Young adult onset Parkinsonism disease

References

  • Albanese A, Barnes MP, Bhatia KP et al (2006) A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 13:433–444

    Article  CAS  PubMed  Google Scholar 

  • Alkufri F, Harrower T, Rahman Y et al (2013) Molybdenum cofactor deficiency presenting with a parkinsonism-dystonia syndrome. Mov Disord 28:399–401

    Article  PubMed  Google Scholar 

  • Anheim M, Lagier-Tourenne C, Stevanin G et al (2009) SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol 256:104–108

    Article  PubMed  Google Scholar 

  • Appenzeller S, Schirmacher A, Halfter H et al (2010) Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene. Am J Hum Genet 86:83–87

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bandettini di Poggio M, Nesti C et al (2013) Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation. BMC Med Genet 14:105

    Article  PubMed Central  PubMed  Google Scholar 

  • Bettencourt C, Lima M (2011) Machado-Joseph Disease: from first descriptions to new perspectives. Orphanet J Rare Dis 6:35

    Article  PubMed Central  PubMed  Google Scholar 

  • Bordelon YM (2013) Clinical neurogenetics: huntington disease. Neurol Clin 31:1085–1094

    Article  PubMed  Google Scholar 

  • Brashear A, Mink JW, Hill DF (2012) ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia. Dev Med Child Neurol 54:1065–1067

    Article  PubMed Central  PubMed  Google Scholar 

  • Burlina AP, Edini C, Burlina AB (2002) Treatment of extrapyramidal symptoms in a patient with homozygous homocystinuria. J Inherit Metab Dis 25(2):135–136

    Article  CAS  PubMed  Google Scholar 

  • Camargos S, Scholz S, Simón-Sánchez J et al (2008) DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 7:207–215

    Article  CAS  PubMed  Google Scholar 

  • Casado M, Molero M, Sierra C, García-Cazorla A, Ormazabal A, Artuch R (2013) Analysis of cerebrospinal fluid γ-aminobutyric acid by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis. [Epub ahead of print]

  • Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C et al (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89:398–406

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chinnery PF, Crompton DE, Birchall D et al (2007) Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 130:110–119

    Article  PubMed  Google Scholar 

  • Costello DJ, Walsh SL, Harrington HJ, Walsh CH (2004) Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J Neurol Neurosurg Psychiatry 75:631–633

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Damásio J, Taipa R, Melo-Pires M et al (2014) Freezing of gait - First motor manifestation in late infantile variant neuronal ceroid lipofuscinosis. Parkinsonism Relat Disord 20:243–244

    Article  PubMed  Google Scholar 

  • Davidzon G, Greene P, Mancuso M et al (2006) Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 59:859–862

    Article  CAS  PubMed  Google Scholar 

  • de Lonlay P, Nassogne MC, van Gennip AH et al (2000) Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation. J Inherit Metab Dis 23:819–825

    Article  Google Scholar 

  • Doorn JM, Kruer MC (2013) Newly characterized forms of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep 13:413

    Article  PubMed  Google Scholar 

  • Edvardson S, Cinnamon Y, Ta-Shma A et al (2012) A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS One 7(5):e36458

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ekinci B, Apaydin H, Vural M, Ozekmekçi S (2004) Two siblings with homocystinuria presenting with dystonia and parkinsonism. Mov Disord 19:962–964

    Article  PubMed  Google Scholar 

  • Evans AH, Costa DC, Gacinovic S et al (2004) L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings. Mov Disord 19:1232–1236

    Article  PubMed  Google Scholar 

  • Fernádez-Álvarez E, Aicardi J (2001) In: Movement disorders in children. Mac Keith, London, pp 24–34

    Google Scholar 

  • Floris G, Borghero G, Cannas A et al (2012) Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? J Neurol 259:1749–1751

    Article  PubMed  Google Scholar 

  • Garcia-Cazorla A, Rabier D, Touati G et al (2006) Pyruvate Carboxylase Deficiency: Metabolic Characteristics and New Neurological Aspects. Ann Neurol 59:121–127

    Article  PubMed  Google Scholar 

  • Garcia-Cazorla A, Duarte S, Serrano M et al (2008) Mitochondrial diseases mimicking neurotransmitter defects. Mitochondrion 8:273–278

    Article  CAS  PubMed  Google Scholar 

  • García-Cazorla A, Ortez C, Pérez-Dueñas B et al (2011) Hypokinetic-rigid syndrome in children and inborn errors of metabolism. Eur J Paediatr Neurol 15:295–302

    Article  PubMed  Google Scholar 

  • Gregory A, Hayflick SJ (2011) Genetics of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep 11:254–261

    Article  CAS  PubMed  Google Scholar 

  • Gregory A, Hayflick S (2013) Neurodegeneration with brain iron accumulation disorders overview. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (eds) Source GeneReviews™ [Internet]. University of Washington, Seattle, pp 1993–2013

    Google Scholar 

  • Guimarães J, Amaral O, Sá Miranda MC (2003) Adult-onset neuronopathic form of Gaucher's disease: a case report. Parkinsonism Relat Disord 9:261–264

    Article  PubMed  Google Scholar 

  • Hall DA, O'keefe JA (2012) Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment. Tremor Other Hyperkinet Mov (N Y) 2: tre-02-56-352-1

  • Hara M, Inokuchi T, Taniwaki T et al (2013) An adult patient with mucolipidosis III alpha/beta presenting with parkinsonism. Brain Dev 35:462–465

    Article  PubMed  Google Scholar 

  • Hsu SC, Sears RL, Lemos RR et al (2013) Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics 14:11–22

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Inzelberg R, Korczyn AD (1994) Parkinsonism in adult-onset GM2 gangliosidosis. Mov Disord 9:375–377

    Article  CAS  PubMed  Google Scholar 

  • Jäggi L, Zurflüh MR, Schuler A et al (2008) Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Mol Genet Metab 93:295–305

    Article  PubMed  Google Scholar 

  • Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376

    Article  CAS  PubMed  Google Scholar 

  • Jinnah HA, Ceballos-Picot I, Torres RJ et al (2010) Attenuated variants of Lesch-Nyhan disease. Brain 2010(133):671–689

    Article  Google Scholar 

  • Keller A, Westenberger A, Sobrido MJ et al (2013) (2013) Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet 45:1077–1082

    Article  CAS  PubMed  Google Scholar 

  • Kiferle L, Orsucci D, Mancuso M et al (2013) Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: A case report and an update on the state of art. Neurosci Lett 27(556):1–4

    Article  Google Scholar 

  • Kikuchi A, Takeda A, Fujihara K (2004) Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report. Mov Disord 19:590–593

    Article  PubMed  Google Scholar 

  • Kilarski LL, Pearson JP, Newsway V et al (2012) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease. Mov Disord 27:1522–1529

    Article  CAS  PubMed  Google Scholar 

  • Kim TJ, Kim IO, Kim WS et al (2006) MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 27(6):1373–1378

    CAS  PubMed  Google Scholar 

  • Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A (2002) A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 70(4):1034–1037

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6:9–13

    Article  CAS  PubMed  Google Scholar 

  • Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A (2013) The current and projected economic burden of Parkinson's disease in the United States. Mov Disord 28(3):311–318

    Article  PubMed  Google Scholar 

  • Krause M, Fogel W, Tronnier V et al (2006) Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 21(12):2255–2257

    Article  PubMed  Google Scholar 

  • Kurian MA, Li Y, Zhen J et al (2011a) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol 10:54–62

    Article  CAS  PubMed  Google Scholar 

  • Kurian MA, Gissen P, Smith M, Heales S Jr, Clayton PT (2011b) The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 10:721–733

    Article  CAS  PubMed  Google Scholar 

  • Kurian MA, Hayflick SJ (2013) Pantothenate Kinase-Associated Neurodegeneration (PKAN) and PLA2G6-Associated Neurodegeneration (PLAN): Review of Two Major Neurodegeneration with Brain Iron Accumulation (NBIA) Phenotypes. Int Rev Neurobiol 110:49–71

    Article  CAS  PubMed  Google Scholar 

  • Le NM, Parikh S (2012) Late infantile neuronal ceroid lipofuscinosis and dopamine deficiency. J Child Neurol 27:234–237

    Article  PubMed  Google Scholar 

  • Lee WT, Weng WC, Peng SF, Tzen KY (2009) Neuroimaging findings in children with paediatric neurotransmitter diseases. J Inherit Metab Dis 32:361–370

    Article  CAS  PubMed  Google Scholar 

  • Longo N (2009) Disorders of biopterin metabolism. J Inherit Metab Dis 32:333–342

    Article  PubMed  Google Scholar 

  • López-Huerta VG, Carrillo-Reid L, Galarraga E (2013) The balance of striatal feedback transmission is disrupted in a model of parkinsonism. J Neurosci 33:4975–4964

    Article  Google Scholar 

  • López-Laso E, Camino R, Mateos ME et al (2007) Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency. J Neurol Sci 256:90–93

    Article  PubMed  Google Scholar 

  • Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH (2004) The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 61:35–38

    Article  PubMed  Google Scholar 

  • Luoma P, Melberg A, Rinne JO et al (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364:875–882

    Article  CAS  PubMed  Google Scholar 

  • Mastrangelo M, Caputi C, Galosi S, Giannini MT, Leuzzi V (2013) Transdermal rotigotine in the treatment of aromatic L-amino acid decarboxylase deficiency. Mov Disord 28:556–557

    Article  PubMed  Google Scholar 

  • Mellick G, Price L, Boyle R (2004) Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord 19:727–729

    Article  PubMed  Google Scholar 

  • Mellick GD, Siebert GA, Funayama M et al (2009) Screening PARK genes for mutations in early-onset Parkinson’s disease patients from Queensland, Australia. Parkinsonism Relat Disord 15:105–109

    Article  PubMed  Google Scholar 

  • Mengel E, Klünemann HH, Lourenço CM et al (2013) Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 8:166

    Article  PubMed Central  PubMed  Google Scholar 

  • Molero-Luis M, Serrano M, Ormazábal A (2013) Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders. Dev Med Child Neurol 55:559–566

    Article  PubMed  Google Scholar 

  • Müller U (2009) The monogenic primary dystonias. Brain 132(Pt 8):2005–2025

    Article  PubMed  Google Scholar 

  • Nicolas G, Pottier C, Maltête D et al (2013) Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology 80:181–187

    Article  CAS  PubMed  Google Scholar 

  • Nijssen PC, Brusse E, Leyten AC, Martin JJ, Teepen JL, Roos RA (2002) Autosomal dominant adult neuronal ceroid lipofuscinosis: parkinsonism due to both striatal and nigral dysfunction. Mov Disord 17:482–487

    Article  PubMed  Google Scholar 

  • Nikoskelainen EK, Marttila RJ, Huoponen K et al (1995) Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 59:160–164

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ormazabal A, Garcıa-Cazorla A, Fernández Y, Fernández-Álvarez E, Campistol J, Artuch R (2005) HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterines. J Neurosci Methods 142:153–158

    Article  CAS  PubMed  Google Scholar 

  • Ortez C, Jou C, Cortès-Saladelafont E et al (2013) Infantile parkinsonism and gabaergic hypotransmission in a patient with pyruvate carboxylase deficiency. Gene 532:302–306

    Article  CAS  PubMed  Google Scholar 

  • Perier C, Vila M (2012) Mitochondrial biology and Parkinson's disease. Cold Spring Harb Perspect Med 2:a009332

    Article  PubMed Central  PubMed  Google Scholar 

  • Pfeiffer RF (2007) Wilson's Disease. Semin Neurol 27:123–132

    Article  PubMed  Google Scholar 

  • Pons R (2009) The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism. J Inherit Metab Dis 32:321–332

    Article  CAS  PubMed  Google Scholar 

  • Pons R, Syrengelas D, Youroukos S et al (2013) Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. Mov Disord 28:1058–1063

    Article  CAS  PubMed  Google Scholar 

  • Puffenberger EG, Jinks RN, Sougnez C et al (2012) Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One 7:e28936

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Puschmann A (2013) Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord 19:407–415

    Article  PubMed  Google Scholar 

  • Quadri M, Cossu G, Saddi V et al (2011) Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia. Neurogenetics 12:203–209

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Quadri M, Federico A, Zhao T et al (2012) Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am J Hum Genet 90:467–477

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Quadri M, Fang M, Picillo M (2013) Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism. Hum Mutat 34:1208–1215

    Article  CAS  PubMed  Google Scholar 

  • Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: A 39-year clinicopathologic study. Neurology 73:206–212

    Article  CAS  PubMed  Google Scholar 

  • Rilstone JJ, Alkhater RA, Minassian BA (2013) Brain dopamine-serotonin vesicular transport disease and its treatment. N Engl J Med 368:543–550

    Article  CAS  PubMed  Google Scholar 

  • Roze E, Paschke E, Lopez N et al (2005) Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 20:1366–1369

    Article  PubMed  Google Scholar 

  • Roze E (2006) Young adult-onset parkinsonism. At Orphanet www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=2828

  • Rubio-Agusti I, Kojovic M, Edwards MJ et al (2012) Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review. Mov Disord 27:1769–1774

    Article  PubMed  Google Scholar 

  • Schneider SA, Paisan-Ruiz C, Quinn NP, Lees AJ, Houlden H, Hardy J, Bhatia KP (2010) ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord 25:979–984

    Article  PubMed  Google Scholar 

  • Sedel F, Saudubray JM, Roze E, Agid Y, Vidailhet M (2008) Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 31:308–318

    Article  CAS  PubMed  Google Scholar 

  • Sharma M, Ioannidis JP, Aasly JO et al (2012) A multicentre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet 49:721–726

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shojaee S, Sina F, Banihosseini SS et al (2008) Genome-wide linkage analysis of a parkinsonian-pyramidal síndrome pedigree by 500 K SNP arrays. Am J Hum Genet 82:1375–1384

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, Johns DR (1999) Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53:1787–1793

    Article  CAS  PubMed  Google Scholar 

  • Simons C, Wolf NI, McNeil N et al (2013) A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet 92:767–773

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sundal C, Fujioka S, Van Gerpen JA et al (2013) Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 19:869–877

    Article  PubMed  Google Scholar 

  • Synofzik M, Asmus F, Reimold M, Schöls L, Berg D (2010) Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism. Mov Disord 25:243–245

    Article  PubMed  Google Scholar 

  • Tarsy D, Simon DK (2006) Dystonia. N Engl J Med 355:818–829

    Article  CAS  PubMed  Google Scholar 

  • Taverna S, Ilijic E, Surmeier DJ (2008) Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28:5504–5512

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Torres RJ, Puig JG (2007) Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis 2:48

    Article  PubMed Central  PubMed  Google Scholar 

  • van Swieten J, Spillantini MG (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17:63–73

    Article  PubMed  Google Scholar 

  • Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5:16

    Article  PubMed Central  PubMed  Google Scholar 

  • Willemsen MA, Verbeek MM, Kamsteeg EJ et al (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 133:1810–1822

    Article  PubMed  Google Scholar 

  • Zafeiriou DI, Willemsen MA, Verbeek MM, Vargiami E, Ververi A, Wevers R (2009) Tyrosine hydroxylase deficiency with severe clinical course. Mol Genet Metab 97:18–20

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledments

This study was funded by the grant FIS PS09/01132.

Currently, Dr. Sofia Duarte integrates the Portuguese Programme for Advanced Medical Education, sponsored by Calouste Gulbenkian Foundation and Portuguese Foundation for Science and Technology.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Garcia-Cazorla.

Additional information

Communicated by: Alberto B. Burlina

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garcia-Cazorla, A., Duarte, S.T. Parkinsonism and inborn errors of metabolism. J Inherit Metab Dis 37, 627–642 (2014). https://doi.org/10.1007/s10545-014-9723-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-014-9723-6

Keywords

Navigation